alpha-gal syndrome

alpha-gal syndrome (AGS), allergic condition in which the immune system reacts to galactose-α-1,3-galactose (alpha-gal), a carbohydrate found in the tissues of most non-primate mammals and typically consumed in meat. AGS is initiated by a tick bite.

Unlike many classic food allergies, which are triggered by proteins and produce symptoms within minutes, AGS features a notoriously delayed mechanism that causes systemic allergic reactions two to eight hours after consuming products that contain alpha-gal. This delay is due mainly to the attachment of alpha-gal to fats, which are digested more slowly than proteins. Meats most commonly linked to AGS are beef, pork, lamb, and venison. However, while AGS is often dubbed the “red meat allergy,” its triggers include a variety of other mammalian products, including dairy, gelatin-based medications, and certain medical stabilizers.

Because symptoms are delayed and variable, many cases go unrecognized. Moreover, although sensitization to alpha-gal is relatively common in some tick-endemic regions, only a subset of sensitized individuals develops clinically significant disease. Owing to these factors, AGS is considered to be severely underdiagnosed worldwide.

Discover how ordinary objects work, and expand your understanding of the familiar.

SIGN UP

" height="20" alt="HEW Logo">

Thank you for signing up!"

Back to homepage

By clicking "Sign Up", you consent to the Britannica Privacy Policy and Terms of Use.

Britannica Quiz

44 Questions from Britannica’s Most Popular Health and Medicine Quizzes

History and distribution

The carbohydrate structure—the alpha-gal epitope (the portion of the molecule that stimulates an immune response)—was first identified in the 1960s on glycolipids from rabbit red blood cells during studies of cell-surface carbohydrates. In 1984–85 it was discovered that humans naturally produce abundant antibodies (anti-Gal) against the alpha-gal epitope, establishing its immunological importance and launching subsequent research into its biological significance.

AGS was recognized in the early 21st century, although isolated cases of delayed allergic reactions following the consumption of red meat had been reported previously and remained unexplained. A major advance occurred in the mid-2000s when physicians observed an unusually high frequency of severe allergic reactions to the cancer drug cetuximab, a monoclonal antibody, among patients in the southeastern United States. Investigators subsequently found that affected individuals possessed immunoglobulin E (IgE) antibodies directed against alpha-gal, which is present on cetuximab as well as in the tissues of most non-primate mammals. Researchers later demonstrated that many of these patients had previously been bitten by the lone star tick (Amblyomma americanum), establishing the first clear link between tick bites and a food allergy.

It was then realized that alpha-gal syndrome occurs in many parts of the world and can be triggered by several tick species, including Ixodes holocyclus in Australia, I. ricinus in Europe, A. sculptum in South America, and Haemaphysalis longicornis and other species in Asia. As awareness of the condition has increased and diagnostic testing has become more widely available, recognized cases have risen substantially, although the syndrome likely remains underdiagnosed in many regions.

Alpha-gal evolution

Alpha-gal occurs naturally on the surface of cells and in the tissues of nearly all non-primate mammals. It is absent, however, from humans, apes, and Old World monkeys, which lost a functional copy of the GGTA1 gene roughly 20 million to 30 million years ago. GGTA1 encodes α-1,3-galactosyltransferase, the enzyme necessary to produce alpha-gal.

Explore Britannica Premium!

The trusted destination for professionals, college students, and lifelong learners.

SUBSCRIBE

Loss of GGTA1 is suspected to have come with an evolutionary trade-off. Under ordinary circumstances, antibodies against alpha-gal contribute to immune defense. Following sensitization triggered by tick bites, however, the immune response can shift toward the production of IgE antibodies, resulting in an allergic reaction upon subsequent exposure to alpha-gal. Genetic factors may also influence susceptibility. In particular, because the blood group B antigen closely resembles alpha-gal, individuals with type B blood appear to have a lower risk of developing AGS, possibly owing to partial immune tolerance.

Transmission and reaction

Unlike infectious tick-borne diseases, AGS is not caused by a microorganism and cannot be transmitted from person to person. Rather, tick bites play a central role in the development of AGS by initiating the immune sensitization that precedes allergic reactions. Although the precise mechanisms remain incompletely understood, evidence indicates that exposure to components of tick saliva stimulates the production of IgE antibodies against alpha-gal in susceptible individuals. Additional constituents of tick saliva, including immunomodulatory molecules that suppress normal immune responses and promote inflammation at the bite site, are also thought to contribute to the development of AGS.

Reactions range from itching, hives, swelling, and gastrointestinal distress to life-threatening anaphylaxis, and their severity varies among individuals and between exposures. Repeated tick bites may increase alpha-gal–specific IgE antibody levels and prolong the condition, whereas avoidance of additional tick bites may allow antibody levels to decline over time, enabling some individuals to regain tolerance to products containing alpha-gal.

Diagnosis and treatment

Diagnosis of AGS is based on a compatible clinical history, including evidence of alpha-gal–specific IgE antibodies in the blood, and, when present, a history of tick exposure. Because symptoms are delayed and variable, many cases initially go unrecognized or are mistaken for other allergic or gastrointestinal disorders.

There is no cure for AGS, and treatment focuses on preventing allergic reactions through avoidance of mammalian meat and other alpha-gal–containing foods or products that trigger symptoms. Acute reactions are managed according to their severity, with antihistamines used for mild symptoms and intramuscular epinephrine administered for anaphylaxis. Individuals at risk for severe reactions are generally advised to carry an epinephrine auto-injector and to avoid additional tick bites, since repeated bites may increase alpha-gal–specific IgE levels and prolong or worsen the condition.